059: Identification of novel subtype-specific alterations as candidates for drug targets and characterization of intratumour genetic heterogeneity and its contribution to therapy resistance in high-grade serous ovarian cancer (HGSOC)

HIPO Investigator:

PD Dr. Frederik Marmé

Dr. Marc Zapatka

Prof. Dr. Peter Lichter

Dr. Martin Sprick

Prof. Dr. Andreas Trumpp

Prof. Peter Sinn

Dr. Monika Hämmerle

Prof. Dr. Barbara Burwinkel

Prof. Dr. Andreas Schneeweiss

Prof. Dr. Benedikt Brors

Entity: HGSOC